[
  {
    "_id": "632de3818001b4e261620240",
    "name": "PMATCH",
    "status": "Submitted"
  },
  {
    "_id": "632de3818001b4e261620241",
    "name": "CoBE",
    "status": "CBMP internal funding"
  },
  {
    "_id": "632de3818001b4e261620242",
    "name": "ORCESTRA - CCS grant",
    "status": "Active",
    "startingDate": "2022-03-30T00:00:00.000Z",
    "deadline": "2023-03-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e261620243",
    "name": "Development of a deep learning approach to predict noisy biological phenotypes (Haibe-Kains B)",
    "status": "Active",
    "startingDate": "2021-04-30T00:00:00.000Z",
    "deadline": "2026-03-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e261620244",
    "name": "Alternatively and trans-spliced isoforms as a new class of biomarkers of response to cytotoxic and targeted therapies in metastatic triple-negative breast cancer (Haibe-Kains B)",
    "status": "Active",
    "startingDate": "2019-09-30T00:00:00.000Z",
    "deadline": "2023-08-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e261620245",
    "name": "Novel individualized therapies in JAK/STAT driven T-cell malignancies (Haibe-Kains B, Gunning P)",
    "status": "Active",
    "startingDate": "2018-11-30T00:00:00.000Z",
    "deadline": "2023-11-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e261620246",
    "name": "Prognostic Biomarkers and Novel Therapies for Oral Squamous Cell Carcinoma Patients (Ailles L, Haibe-Kains B)",
    "status": "Active",
    "startingDate": "2020-02-01T00:00:00.000Z",
    "deadline": "2025-01-01T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e261620247",
    "name": "Genomics-based radiosensitization for HPV-negative squamous cell carcinoma of the aerodigestive tract (Bratman S, Haibe-Kains B)",
    "status": "Active",
    "startingDate": "2019-01-30T00:00:00.000Z",
    "deadline": "2023-11-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e261620248",
    "name": "The characterization and therapeutic targeting of aberrant metabolic and inflammatory signaling in chronic lymphedema (Fei-Fei L)",
    "status": "Active",
    "startingDate": "2021-07-30T00:00:00.000Z",
    "deadline": "2026-06-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e261620249",
    "name": "Leiomyosarcoma (LMS): New Targets, New Therapies, New Models (Baker L)",
    "status": "Active",
    "startingDate": "2019-04-30T00:00:00.000Z",
    "deadline": "2022-09-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e26162024a",
    "name": "iTNT - The Immunotherapy Network (Ohashi P, Nelson B, Haibe-Kains B, others)",
    "status": "Active",
    "startingDate": "2015-09-30T00:00:00.000Z",
    "deadline": "2023-03-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e26162024b",
    "name": "Development of drug combinations in acute myeloid leukemia (Haibe-Kains B, Schimmer A)",
    "status": "Active",
    "startingDate": "2016-04-30T00:00:00.000Z",
    "deadline": "2023-03-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e26162024c",
    "name": "PM Research Stimulus Grant: PharmacoDB + XevaDB",
    "status": "Active",
    "startingDate": "2021-09-30T00:00:00.000Z",
    "deadline": "2022-09-30T00:00:00.000Z"
  },
  {
    "_id": "632de3818001b4e26162024d",
    "name": "Roche:RAAN Challenge",
    "status": "Active",
    "startingDate": "2021-12-30T00:00:00.000Z",
    "deadline": "2022-12-30T00:00:00.000Z"
  }
]